SunWay Biotech Co., LTD. Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	680.88	293.71	362.19	123.57	346.44	295.34
Cash & Short-Term Investments	680.88	293.71	362.19	123.57	346.44	295.34
Cash Growth	118.12%	-18.91%	193.11%	-64.33%	17.30%	351.96%
Accounts Receivable	231.87	298.3	266.47	170.66	102.45	45.97
Other Receivables	-	-	-	-	-	0.13
Receivables	231.87	298.3	266.47	206.91	102.45	46.1
Inventory	262.64	210.03	170.23	94	76.91	90.01
Prepaid Expenses	11.31	15.46	9.13	12.26	2.84	2.93
Other Current Assets	9.05	7.99	4.74	3.83	-	-
Total Current Assets	1,196	825.48	812.76	440.56	528.63	434.38
Property, Plant & Equipment	325.7	337.12	319.45	5.43	48.64	15.3
Long-Term Investments	11.75	12.97	7.76	-	5.34	4.4
Goodwill	2,027	2,027	2,027	-	-	-
Other Intangible Assets	370.22	392.16	429.39	16.85	11.68	12.83
Long-Term Deferred Tax Assets	4.68	4.22	6.97	5.92	-	-
Other Long-Term Assets	230.54	193.76	136.53	9.47	13.41	44.25
Total Assets	4,165	3,792	3,740	478.23	607.7	511.15
Accounts Payable	44.34	51.54	35.72	57.96	18.59	15.57
Accrued Expenses	-	-	-	-	29.87	18.82
Short-Term Debt	310	-	7.51	65.56	-	-
Current Portion of Leases	13.2	17.04	31.55	2.4	2.51	2.43
Current Income Taxes Payable	22.65	24.63	18.43	7.39	0.49	-
Current Unearned Revenue	13.63	13.65	15.89	14.95	0.84	3.95
Other Current Liabilities	216.52	116.57	94.3	38.84	8.34	5.76
Total Current Liabilities	620.33	223.44	203.4	187.1	60.65	46.53
Long-Term Leases	220.37	226.95	248.3	3.05	-	-
Long-Term Deferred Tax Liabilities	70.93	75.08	82.24	-	-	-
Other Long-Term Liabilities	27.74	1.66	3.28	-	-	-
Total Liabilities	939.36	527.13	537.21	190.14	60.65	46.53
Common Stock	603.89	603.89	593.89	209.19	331.35	329.95
Additional Paid-In Capital	2,524	2,524	2,555	-	29.08	39.23
Retained Earnings	94.82	131.06	51.09	32.82	195.83	106.55
Comprehensive Income & Other	1.81	3.36	-0.68	46.08	-12.6	-13.54
Total Common Equity	3,223	3,263	3,199	288.09	543.66	462.19
Minority Interest	2.61	2.6	2.89	-	3.39	2.44
Shareholders' Equity	3,226	3,265	3,202	288.09	547.05	464.62
Total Liabilities & Equity	4,165	3,792	3,740	478.23	607.7	511.15
Total Debt	543.57	243.99	287.35	71.01	2.51	2.43
Net Cash (Debt)	137.31	49.71	74.84	52.57	343.93	292.91
Net Cash Growth	261.62%	-33.57%	42.37%	-84.72%	17.42%	446.19%
Net Cash Per Share	2.27	0.82	2.44	2.60	10.01	9.02
Filing Date Shares Outstanding	60.39	60.39	60.39	34.11	33.69	33.55
Total Common Shares Outstanding	60.39	60.39	60.39	34.11	33.69	33.55
Working Capital	575.41	602.04	609.36	253.47	467.99	387.85
Book Value Per Share	53.38	54.03	52.98	8.44	16.14	13.78
Tangible Book Value	826.43	843.81	743.36	271.24	531.98	449.36
Tangible Book Value Per Share	13.69	13.97	12.31	7.95	15.79	13.39
Machinery	91.02	100.91	102.56	1.78	129.24	88.42
Construction In Progress	59.4	57.04	31.9	-	-	-
Leasehold Improvements	49.51	58.95	25.58	-	23.19	23.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.